Vivani Medical, Inc. Shareholders' Equity
Vivani Medical, Inc. (VANI) had Shareholders' Equity of $18.97 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-13
- 2026-06-30: Stockholders' Equity Attributable to Parent $18.97M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $19.09M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $15.73M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $1.31M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $18.97M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $19.09M 10-Q · filed 2026-08-13 | |
| 2025-12-31 | $15.73M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $1.31M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $4.91M 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $11.62M 10-Q · filed 2026-08-13 | |
| 2024-12-31 | $17.61M 10-Q · filed 2026-08-13 | |
| 2024-09-30 | $18.33M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $23.82M 10-Q · filed 2025-11-13 | |
| 2024-03-31 | $28.71M 10-Q · filed 2025-11-13 | |
| 2023-12-31 | $20.76M 10-K · filed 2026-03-26 | |
| 2023-09-30 | $26.21M 10-Q · filed 2024-11-13 | |
| 2023-06-30 | $32.39M 10-Q · filed 2024-11-13 | |
| 2023-03-31 | $38.37M 10-Q · filed 2024-11-13 | |
| 2022-12-31 | $44.31M 10-K · filed 2025-03-31 | |
| 2022-09-30 | $51.36M 10-Q · filed 2023-11-13 | |
| 2022-06-30 | -$4.82M 10-Q · filed 2023-11-13 | $63.06M 10-Q · filed 2022-08-12 |
| 2022-03-31 | -$1.12M 10-Q · filed 2023-11-13 | $66.15M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $2.46M 10-K · filed 2024-03-26 | $68.36M 10-K · filed 2022-03-29 |
| 2021-09-30 | $1.43M 10-Q · filed 2022-11-14 | $69.61M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $1.40M 10-Q · filed 2022-11-14 | $72.10M 10-Q · filed 2021-08-13 |
| 2021-03-31 | $1.60M 10-Q · filed 2022-11-14 | $21.01M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $1.95M 10-K · filed 2023-03-31 | -$672.00K 10-K · filed 2021-03-16 |
| 2020-09-30 | $542.00K 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $2.08M 10-Q · filed 2021-11-12 | |
| 2020-03-31 | -$1.32M 10-Q · filed 2021-11-12 | |
| 2019-12-31 | $7.28M 10-K · filed 2022-03-29 | |
| 2019-09-30 | $14.29M 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $21.20M 10-Q · filed 2020-11-12 | |
| 2019-03-31 | $28.53M 10-Q · filed 2020-11-12 | |
| 2018-12-31 | $3.08M 10-K · filed 2021-03-16 | |
| 2018-09-30 | $3.89M 10-Q · filed 2019-11-14 | |
| 2018-06-30 | $6.54M 10-Q · filed 2019-11-14 | |
| 2018-03-31 | $3.53M 10-Q · filed 2019-11-14 | |
| 2017-12-31 | $7.88M 10-K · filed 2020-03-19 | |
| 2017-09-30 | $12.97M 10-Q · filed 2018-11-08 | |
| 2017-06-30 | $18.80M 10-Q · filed 2018-11-08 | |
| 2017-03-31 | $24.36M 10-Q · filed 2018-11-08 | |
| 2016-12-31 | $11.15M 10-K · filed 2019-03-19 | |
| 2016-09-30 | $20.60M 10-Q · filed 2017-11-06 | |
| 2016-06-30 | $28.09M 10-Q · filed 2017-08-07 | |
| 2016-03-31 | $15.94M 10-Q · filed 2017-05-09 | $15.94K 10-Q · filed 2016-05-06 |
| 2015-12-31 | $20.26M 10-K · filed 2019-03-19 | |
| 2015-09-30 | $24.50M 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $28.10M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $30.46M 10-Q · filed 2015-05-15 | |
| 2014-12-31 | $34.62M 10-K · filed 2018-03-20 | $34.62M 10-Q · filed 2015-05-15 |
| 2013-12-31 | -$9.22M 10-K · filed 2017-03-16 | |
| 2012-12-31 | -$3.04M 10-K · filed 2016-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| IRIDEX CORP (IRIX) | United States | $0.011B |